Playback speed
10 seconds
AHA 2023 Insights: Target-HTN: Trial on the Safety and Efficacy of Lorundrostat (MLS-101) in Patients with Uncontrolled Hypertension
By
AHA 2023 Insights
FEATURING
Luke Laffin
By
AHA 2023 Insights
FEATURING
Luke Laffin
322 views
November 20, 2023
Login to view comments.
Click here to Login